Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 69452-353

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 69452-353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

180slabel (Image001)

180slabel (Image001)
This is a description of Amprosate Calcium Delayed-Release Tablets, a prescription medication containing 180 tablets. Each enteric-coated tablet contains 333 mg of amprosate calcium, equivalent to 10300 mg of acamprosate. The usual dosage information is provided in the package insert. The storage instructions recommend keeping it at 20°C to 25°C (66°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It is advised to keep this medication and all drugs out of reach of children and dispense it in a tightly closed container as described in the USP guidelines. The product is distributed by Bionpharma Inc. and is manufactured in India. The code for the product is THDugs THOOD02222006.*
FDA Label Image

Structure.jpg (Structure001)

Structure.jpg (Structure001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.